PYC Therapeutics Ltd
ASX:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
T
|
Techstep ASA
OSE:TECH
|
NO |
|
S
|
Soder Sportfiske AB
STO:SODER
|
SE |
|
Antibe Therapeutics Inc
TSX:ATE
|
CA |
|
T
|
TQM Alpha PCL
SET:TQM
|
TH |
|
Rocky Mountain Chocolate Factory Inc (Delaware)
NASDAQ:RMCF
|
US |
Wall Street
Price Targets
PYC Price Targets Summary
PYC Therapeutics Ltd
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.48 AUD
with a low forecast of 2.27 AUD and a high forecast of 4.47 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PYC's stock price target?
Price Target
3.48
AUD
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.48 AUD
with a low forecast of 2.27 AUD and a high forecast of 4.47 AUD.
What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
66%
For the last 13 years the
compound annual growth rate for
PYC Therapeutics Ltd's revenue is
22%.
The projected
CAGR
for the next 3 years is
66%.
